Features | Partner Sites | Information | LinkXpress
Sign In
SCHILLER AG
Advantech Europe
FLUKE BIOMEDICAL

ECG Tool Analyzes Ischemic Heart Disease

By HospiMedica International staff writers
Posted on 16 Dec 2013
Image: The CS-200 Excellence - a multifunctional diagnostic system (Photo courtesy of Schiller).
Image: The CS-200 Excellence - a multifunctional diagnostic system (Photo courtesy of Schiller).
A multifunctional cardiac assessment system for exercise stress testing set new standards for the future of electrocardiography.

The CS-200 Excellence is equipped with the 3rd Generation Intel Core i7 CPU, which speeds up the entire system, as well as a very high sampling rate of 8,000 Hz per channel, allowing the accurate recording of even slight changes in the electrocardiogram (ECG). The i7 CPU core allows 16-channel resting and exercise ECG measurement with 4-bit resolution of the ECG signal; QTC calculation (user-defined); autonomous emergency ECG; automatic measurement and interpretation; and repeated analysis of the 10-second ECG.

An array of high-performance analysis and diagnostic tools enhance the multifunctional diagnostic system, which has also been fitted with groundbreaking HyperQ technology for coronary artery disease (CAD) screening and acute coronary syndrome (ACS) detection. When combined with the CS-200 Excellence, HyperQ enables the detection of depolarization changes in both resting and exercise ECGs by means of automated analysis of the high-frequency QRS components.

The CS-200 Excellence also helps to optimize digital workflow by offering connectivity to electronic medical records (EMRs), the SEMA cardiology information system, and picture archiving and communications systems (PACS). Results are displayed on a 24-inch liquid crystal display (LCD) monitor, while an integrated thermal printer and rechargeable battery ensure immediate real-time printouts at any time. The CS-200 Excellence is a product of Schiller (Baar, Switzerland).

Related Links:

Schiller 



Channels

Women's Health

view channel

Low-Dose Aspirin Will Not Prevent Pregnancy Loss

A new study reveals that in general, low-dose aspirin is not beneficial for future pregnancy outcomes in women with prior pregnancy loss. Researchers at the University at Buffalo (NY, USA) conducted a placebo-controlled trial that included 1,228 women (aged 18-40 years) who were attempting to become pregnant.... Read more

Business

view channel

Infusion Pumps Propel Global Market Upwards

The global infusion pumps market is expected to grow at a compound annual growth rate (CAGR) of 5.3%, reaching an estimated value of USD 7.8 billion in 2019. These are the latest findings of Transparency Market Research (Albany, NY, USA), a global market intelligence company. Infusion pumps are used to deliver therapeutic... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.